Salesforce falls as Morgan Stanley cuts target to $185
Morgan Stanley downgraded Salesforce to Equal-Weight and slashed its price target to $185, citing delays in AI monetization and drag from legacy assets. The move follows similar caution from CLSA and Evercore, while sector weakness was exacerbated by IBM's disappointing earnings. Technical indicators show the stock trading below key moving averages with a bearish bias.

*this image is generated using AI for illustrative purposes only.
Salesforce, Inc. (NYSE: CRM) stock declined on Tuesday after Morgan Stanley downgraded the company from Overweight to Equal-Weight and lowered its price forecast to $185 from $287. The revision reflects concerns that AI momentum has yet to materially improve organic revenue growth, as legacy assets like Commerce and Tableau continue to drag performance. The firm noted that while Agentforce KPIs are inflecting, the monetization of the "agentic pivot" toward headless software is still nascent and will likely take longer than expected to drive growth.
The downgrade follows recent rating actions from other Wall Street firms. On July 20, CLSA initiated coverage with a Hold rating and a $165 price forecast. Earlier, on July 14, Evercore ISI Group maintained an Outperform rating but reduced its price target from $260 to $250, following a downgrade by Keybanc to Sector Weight.
Sector Weakness and IBM Impact
Sector pressure intensified on July 14 when Salesforce shares fell alongside International Business Machines Corp (NYSE: IBM). IBM reported preliminary second-quarter revenue of $17.2 billion, missing the $17.86 billion consensus estimate, and adjusted EPS of $2.93 against a $3.02 estimate. CEO Arvind Krishna described the results as "disappointing," citing a shortfall in the Z mainframe business and software stack as clients shifted capital expenditure toward hardware purchases.
Technical Analysis
Salesforce is trading below key moving averages, indicating a bearish longer-term bias. The stock is approximately 17.5% below its 200-day SMA ($207.80) and 4.2% below its 100-day SMA ($178.89). While it holds about 4.5% above the 20-day SMA ($164.04), the 20-day remains below the 50-day SMA ($171.15), a short-term bearish alignment. The RSI is neutral at 53.50.
| Metric | Level |
|---|---|
| Key Resistance | $187.50 |
| Key Support | $171 |
| 200-day SMA | $207.80 |
| 100-day SMA | $178.89 |
| 50-day SMA | $171.15 |
Salesforce shares were down 2.14% at $170.07 at the time of publication.
What specific milestones or metrics does Salesforce need to hit to prove that Agentforce can successfully monetize the 'agentic pivot'?
How long can legacy assets like Commerce and Tableau continue to underperform before Salesforce considers strategic divestitures?
Will the recent weakness in IBM's mainframe and software businesses serve as a leading indicator for further enterprise software spending slowdowns?

































